Taj Pharmaceuticals as Manufacturer of Tacrolimus Capsules IP 0.5mg (TACROTAJ) Tacrolimus Capsules IP 0.5mg (TACROTAJ) manufacturer in India {Taj Pharmaceuticals}; best quality supplier and exporter of Tacrolimus Capsules IP 0.5mg (TACROTAJ) Taj Pharmaceuticals manufactures a wide range of pharmaceuticals formulation involving Ointment/Ointment/ and Orals. Taj Pharma India team has an excellent expertise in manufacturing and export of Tacrolimus Capsules IP 0.5mg (TACROTAJ) Taj Pharmaceuticals places its main business as a Pharmaceuticals manufacturing and exports of generic drug supply of Tacrolimus Capsules IP 0.5mg (TACROTAJ); primarily of pharmaceuticals preparations known as Tacrolimus Capsules IP 0.5mg (TACROTAJ); as well as more than 100+ generic equivalent drug. Taj Pharmaceuticals has performed these business activities related to exports of Tacrolimus Capsules IP 0.5mg (TACROTAJ) for major foreign-affiliated pharmaceutical import companies, ministry of health, tenders etc. and have enjoyed the full confidence of these companies, instructions and governments. Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Tacrolimus Capsules IP 0.5mg (TACROTAJ); at Taj Pharma we will appropriately meet diverse needs for Tacrolimus Capsules IP 0.5mg (TACROTAJ) export manufacturing in a wide range of activities from investigation of possible formulations of Tacrolimus Capsules IP 0.5mg (TACROTAJ), formulation development, making applications to the international regulatory authorities for marketing approval, validation of Tacrolimus Capsules IP 0.5mg (TACROTAJ) through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group. We at Taj Pharma intend to make our manufacturing systems comply with the requirements of the FDA (cGMP) such that pilot plant scale production of products in the stage of clinical development or for use in clinical studies, as well as manufacture of products in small lots are practicable to ensure a highly stable pharmaceuticals formulations of generic equivalent and bio-similar products. We conduct extensive bio-similar and bio-equivalency studies for all our formations